Page 77 - Bio Engineering Approaches to Cancer Diagnosis and Treatment
P. 77

4.2 Antibody based targeted therapy    75




                  therapy is selectivity, in other words, the ability to detect and remove tumor cells and
                  destroy them without damaging normal cells; this method has been highly respected
                  by researchers.


                  4.2.1  The mechanism of antibody based targeted therapy
                  Antibodies exhibit therapeutic effects by targeting the surface expressed antigens on
                  cancer cells (Fig. 4.1). Before investigating the mechanisms of antibody activity on
                  cancer cells, it is necessary to briefly describe their characteristics, while we were
                  covered them in detail in the previous sections.
                     Antibodies, commonly used in form of immunoglobulins, are proteins that have
                  two binding arms. Antigen-binding portion and  Fc-region that is responsible for
                  binding to serum proteins (complement) or cells. The use of antibodies for treatment
                  of cancer is divided into two general methods:

                  -  An antibody directly and by alterations in intracellular signaling or inhibition
                     of function of growth factor receptors or inhibition of function of adhesion
                     molecules causes tumor cell apoptosis [13].
                  -  Antibody itself does not have the responsibility to kill the target cells, but
                     instead marks the target cells that other components or effector cells of the
                     body’s immune system can attack the cell. The mechanisms for attacking the
                     labeled cells with the antibodies are made from two paths:
                  -  Antibody dependent cellular cytotoxicity (ADCC)
                  -  Antibody-dependent complement mediated cytotoxicity (CMC)
                     ADCC includes the identification of the antibodies by immune system cells that
                  interact with antibody marked cells directly or through other cells (Fig. 4.2). And
                  CMC is a process in which different complement proteins act as cascades; it usually
                  happens when there are several immunoglobulins in close proximity to each other
                  that either directly lead to cell lysis or indirectly invoke other immune system cells
                  to this location [14].



















                  FIGURE 4.1  The mechanism of antibody based targeted therapy.
   72   73   74   75   76   77   78   79   80   81   82